RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Pharmaceutical Industry

A collection of news and information related to Pharmaceutical Industry published by this site and its partners.

Top Pharmaceutical Industry Articles

Displaying items 12-22
  • Business Highlights

    ___ HJ Heinz buys Kraft to build $28 billion food giant Some of the most familiar names in ketchup, pickles, cheese and hot dogs are set to come under the same roof after H.J. Heinz Co. announced plans Wednesday to buy Kraft and create one of the world'...
  • A look at some key statistics on rare diseases in the US

    The global pharmaceutical industry is make huge investments in treatments for rare diseases, which once drew little interest from major drugmakers. A look at some key statistics on rare diseases: ___ — Patients with a rare disease in the U.S.:...
  • Science, patients driving rare disease drug research surge

    The global pharmaceutical industry is pouring billions of dollars into developing treatments for rare diseases, which once drew little interest from major drugmakers but now point the way toward a new era of innovative therapies and big profits. The...
  • Biogen Idec shortens its name to Biogen

    Biogen Idec Inc. is shortening its name to just Biogen as of Monday. The biotechnology company is also introducing a new corporate logo. But it will maintain "BIIB" as its ticker symbol. It said the moves reflects both its evolution and focus on...
  • FDA panel backs Glaxo inhaler for adults, not adolescents

    Government health advisers say a once-a-day respiratory inhaler from GlaxoSmithKline appears safe and effective for adults with asthma, but not for adolescents. The Food and Drug Administration panel of experts voted 18-2 that evidence submitted by the...
  • Baltimore biotech lands FDA approval of drug for rare digestive illness

    Baltimore biotech lands FDA approval of drug for rare digestive illness
    The Food and Drug Administration on Tuesday approved Cholbam, developed by Baltimore biotechnology company Asklepion Pharmaceuticals, for treatment of a rare disease that prevents people from making key digestive acids. The approval means Retrophin, a...
  • Allergan sale to Actavis complete; CEO David Pyott is leaving

    Allergan sale to Actavis complete; CEO David Pyott is leaving
    The $70-billion purchase of Botox maker Allergan Inc. of Irvine by Irish company Actavis has closed, Actavis confirmed Tuesday. Allergan’s longtime leader, David E.I. Pyott, will not have a position in the new company, which will be called...
  • Endo withdraws Salix offer after Valeant raises its bid

    RALEIGH, N.C. Endo International has withdrawn its stock and cash offer for Salix Pharmaceuticals after Valeant Pharmaceuticals raised its Salix bid from $158 per share to $173 per share. The moves seemingly end a 9-month battle for Raleigh-based Salix,...
  • Valeant ups Salix bid to $11.11B and Endo ends quest

    Valeant raised its offer for Salix Pharmaceuticals Ltd. by more than $1 billion Monday, forcing rival bidder Endo International out of the running. Canada's Valeant Pharmaceuticals International Inc. said it would pay $11.11 billion in cash, or $173...
  • Specialty drugs save lives, come with daunting price tags

    Mati Munoz lost her liver to hepatitis C, and the virus was attacking its transplanted replacement last year when her doctor prescribed a drug combination that could save the organ. She just needed $7,000 for an initial payment not covered by her...
  • MedImmune tapping local partners to speed discoveries

    MedImmune tapping local partners to speed discoveries
    The story of MedImmune, the Maryland startup that British pharmaceutical giant AstraZeneca bought for $15.6 billion in 2007, is an example for entrepreneurs striving for their own blockbuster deals. But MedImmune leaders say they want to go beyond leading...